Reactions 1704, p166 - 2 Jun 2018 Parkinsonian symptoms: case report A 70-year-old woman developed parkinsonian symptoms during treatment with fluphenazine [route, dosage, duration of treatment to reaction onset and outcome not stated]. She had a history of Alzheimer’s dementia, hypertension, schizophrenia, major depressive disorder, gait impairment and encephalopathy. She was admitted at a skilled nursing facility for post-acute care following prolonged hospitalisation for encephalopathy. She was recently treated with fluphenazine for schizophrenia. Subsequently, she developed parkinsonian symptoms. Consequently, fluphenazine was stopped. The development of parkinsonian symptoms was considered to be associated to fluphenazine therapy. Author comment: "The patient had been recently treated with fluphenazine for schizophrenia, but was weaned off as she developed an adverse reaction with parkinsonian symptoms." Oh H. Walking with modafinil: A case report on an individual with moderate Alzheimer’s disease. Journal of the American Geriatrics Society 66 (Suppl. 2): S99 (plus poster) abstr. B17, Apr 2018. Available from: URL: http://doi.org/10.1111/ jgs.15376 [abstract] - USA 803323829 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera